| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2136dcb1b8e4a00258b34027b0f2e00 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14 |
| filingDate |
2004-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9ace695ced7833932f75fe70b29eab5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ab4f6253b4fa44e3e26aad706d00546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1646495c1c499bde3289913324e6e952 |
| publicationDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005010171-A1 |
| titleOfInvention |
Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract |
| abstract |
Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008183237-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10932849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758305-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010057178-A1 |
| priorityDate |
1998-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |